Page last updated: 2024-10-24

cefuroxime and Chylopericardium

cefuroxime has been researched along with Chylopericardium in 3 studies

Cefuroxime: Broad-spectrum cephalosporin antibiotic resistant to beta-lactamase. It has been proposed for infections with gram-negative and gram-positive organisms, GONORRHEA, and HAEMOPHILUS.
cefuroxime : A 3-(carbamoyloxymethyl)cephalosporin compound having a 7-(2Z)-2-(furan-2-yl)-2-(methoxyimino)acetamido side chain.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19901 (33.33)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Soh, MC1
Hart, HH1
Corkill, M1
Petzsch, M1
Leber, W1
Westphal, B1
Crusius, S1
Reisinger, EC1
Martini, N1
Xerri, L1
Puchetti, V1

Other Studies

3 other studies available for cefuroxime and Chylopericardium

ArticleYear
Pericardial effusions with tamponade and visceral constriction in patients with rheumatoid arthritis on tumour necrosis factor (TNF)-inhibitor therapy.
    International journal of rheumatic diseases, 2009, Volume: 12, Issue:1

    Topics: Adalimumab; Adult; Anti-Bacterial Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized;

2009
Progressive Staphylococcus lugdunensis endocarditis despite antibiotic treatment.
    Wiener klinische Wochenschrift, 2004, Feb-16, Volume: 116, Issue:3

    Topics: Abscess; Aged; Aorta, Thoracic; Aortic Valve; Cefuroxime; Disease Progression; Dose-Response Relatio

2004
Cefuroxime concentrations in pericardial fluid.
    The Journal of antimicrobial chemotherapy, 1981, Volume: 7, Issue:1

    Topics: Cefuroxime; Cephalosporins; Humans; Kinetics; Pericardial Effusion

1981